Overview
Location
United States
Employees
51-200
Founded date
2022
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 8, 2024 | Bridging the Gap: The Crucial Role of Pharmacogenomics in Mental Health Treatment | In the realm of mental health, the quest for effective treatment often resembles a game of chance. Patients shuffle through a deck of medications, hoping to find the right fit. The stakes are high. Lives hang in the balance. Yet, a powerful... |
| Oct 8, 2024 | Pharmacogenomic Testing in Mental Health: The Need for a Broader Approach | Kristine Ashcraft, President and Founder of YouScript (an Aranscia company) What if we advised people to wear seatbelts only on certain days or when driving on specific highways? Clearly, this would result in real and avoidable harm. Unfort... |
| Nov 20, 2023 | Aranscia Acquires YouScript from Invitae | Pioneering Pharmacogenomics Platform Joins Portfolio of Complementary Precision Medicine Workflow Solutions Aranscia, a global provider of diagnostics software, services, and testing solutions, and Invitae Corporation, a leading medical gen... |
Reviews 0
FAQ about Aranscia
When was Aranscia founded?
Aranscia was founded in 2022.
What has the press written about Aranscia?
Parsers VC has collected 4 articles mentioning Aranscia, among them “Bridging the Gap: The Crucial Role of Pharmacogenomics in Mental Health Treatment” (Oct 8, 2024) and “Pharmacogenomic Testing in Mental Health: The Need for a Broader Approach” (Oct 8, 2024).
Is Aranscia still active?
Yes, Aranscia is active; its latest activity on Parsers VC dates from Jan 23, 2026.